{"id":51093,"date":"2022-11-21T18:02:30","date_gmt":"2022-11-21T17:02:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/"},"modified":"2022-11-21T18:02:30","modified_gmt":"2022-11-21T17:02:30","slug":"millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/","title":{"rendered":"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires MycoScience"},"content":{"rendered":"
\n

WASHINGTON–(BUSINESS WIRE)–Millstone Medical Outsourcing (\u201cMillstone\u201d), the industry\u2019s leading partner of choice for medical manufacturers\u2019 post-manufacturing and aftermarket services, announces its completed acquisition of MycoScience, on November 14, 2022.\n<\/p>\n

\nHeadquartered in Willington, Connecticut, MycoScience has over 30 years of expertise in medical device and pharmaceutical laboratory testing, environmental testing, and related regulatory support services. The company is an ISO 13485:2016 certified contract manufacturing organization operating out of an FDA-registered facility with a rigorous approach to quality that will uphold Millstone\u2019s commitment to operating under the highest quality standards.\n<\/p>\n

\nThe addition of MycoScience to Millstone brings advanced laboratory and environmental testing services with longstanding industry and regulatory experience to Millstone\u2019s capabilities. Post-acquisition, Millstone can complete these adjacent services for its customers in-house, with better controls around product testing. Being able to offer these services in-house will accelerate customer time to market and lessen lead times for in-process testing within production. The addition of MycoScience also enhances Millstone\u2019s ability to offer comprehensive end-to-end services through its Tier 1 approach to expert sourcing and support.\n<\/p>\n

\nMatt Altman, a Managing Partner at Arlington Capital Partners, said, \u201cMycoScience is a highly strategic and complementary acquisition that provides Millstone with broader testing capabilities that can be leveraged across its customer set. We are excited by the growth opportunities this combination will create for Millstone and its customers.\u201d\n<\/p>\n

\n\u201cWith the acquisition of MycoScience, we can offer our customers more support and better controls around product testing, with a single expert point of contact,\u201d Millstone Medical Outsourcing CEO Karl Neuberger said. \u201cThe more advanced and thorough post-manufacturing and aftermarket services we can offer our customers, the more we can support them in creating and accelerating products that change patients\u2019 lives. This acquisition brings together two companies aligned on commitment to quality, expertise, and outstanding customer service.\u201d\n<\/p>\n

\nMycoScience\u2019s leadership team will remain at the helm. MycoScience CEO Sarath Koruprolu noted, \u201cOver the last 30 years, MycoScience has helped our customers bring amazing new devices and medicines to market for better patient outcomes. Now, as we begin a new chapter with Millstone, we look forward to continuing to apply our expertise to product testing, quality, and advancements as a part of the industry partner of choice.\u201d\n<\/p>\n

\nGordon Auduong, a Principal at Arlington Capital Partners, added, \u201cMycoScience\u2019s testing capabilities are a natural extension to Millstone\u2019s current post-manufacturing and distribution & logistics services that will allow Millstone to provide further value to its customers. We are excited to partner with the MycoScience management team and continue their impressive growth as part of the Millstone platform.\u201d\n<\/p>\n

\nAbout Millstone Medical Outsourcing<\/b>\n<\/p>\n

\nMillstone Medical Outsourcing is a leading provider of customized outsourcing solutions to the medical device industry with a client roster of the most prominent global OEMs as well as emerging growth companies. Millstone delivers superior quality service, unparalleled expertise, and guaranteed ROI. The company offers advanced inspection, sterile and non-sterile packaging, loaner kit processing, and distribution services to device and product manufacturers worldwide. Millstone is privately held and operates state-of-the-art facilities in Fall River, MA, and Olive Branch, MS. The company is FDA registered and ISO certified by BSI, Inc. to ISO 13485: 2016.\n<\/p>\n

\nFor more information: www.millstonemedical.com<\/a>\n<\/p>\n

\nAbout Arlington Capital Partners<\/b>\n<\/p>\n

\nArlington Capital Partners is a Washington, DC-based private equity firm that has managed approximately $7 billion in capital commitments. Arlington is focused on middle market investment opportunities in growth industries including healthcare, government services and technology, aerospace & defense, and business services and software. The firm\u2019s professionals and network have a unique combination of operating and private equity experience that enable Arlington to be a value-added investor. Arlington invests in companies in partnership with high quality management teams that are motivated to establish and\/or advance their company\u2019s position as leading competitors in their field.\n<\/p>\n

\nFor more information: www.arlingtoncap.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMatt Altman & Gordon Auduong
\n
Arlington Capital Partners
\n
5425 Wisconsin Avenue, Suite 200
\n
Chevy Chase, MD 20815
\n
(202) 337-7500\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WASHINGTON–(BUSINESS WIRE)–Millstone Medical Outsourcing (\u201cMillstone\u201d), the industry\u2019s leading partner of choice for medical manufacturers\u2019 post-manufacturing and aftermarket services, announces its completed acquisition of MycoScience, on November 14, 2022. Headquartered in Willington, Connecticut, MycoScience has over 30 years of expertise in medical device and pharmaceutical laboratory testing, environmental testing, and related regulatory support services. The company … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51093","6":"format-standard","7":"category-industry"},"yoast_head":"\nMillstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires MycoScience - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires MycoScience - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WASHINGTON–(BUSINESS WIRE)–Millstone Medical Outsourcing (\u201cMillstone\u201d), the industry\u2019s leading partner of choice for medical manufacturers\u2019 post-manufacturing and aftermarket services, announces its completed acquisition of MycoScience, on November 14, 2022. Headquartered in Willington, Connecticut, MycoScience has over 30 years of expertise in medical device and pharmaceutical laboratory testing, environmental testing, and related regulatory support services. The company ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-21T17:02:30+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires MycoScience\",\"datePublished\":\"2022-11-21T17:02:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\\\/\"},\"wordCount\":660,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\\\/\",\"name\":\"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires MycoScience - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-11-21T17:02:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires MycoScience\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires MycoScience - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/","og_locale":"en_US","og_type":"article","og_title":"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires MycoScience - Pharma Trend","og_description":"WASHINGTON–(BUSINESS WIRE)–Millstone Medical Outsourcing (\u201cMillstone\u201d), the industry\u2019s leading partner of choice for medical manufacturers\u2019 post-manufacturing and aftermarket services, announces its completed acquisition of MycoScience, on November 14, 2022. Headquartered in Willington, Connecticut, MycoScience has over 30 years of expertise in medical device and pharmaceutical laboratory testing, environmental testing, and related regulatory support services. The company ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-21T17:02:30+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires MycoScience","datePublished":"2022-11-21T17:02:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/"},"wordCount":660,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/","url":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/","name":"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires MycoScience - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-11-21T17:02:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires MycoScience"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51093","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51093"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51093\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51093"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51093"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}